Sleep therapy shows promise for veterans battling PTSD and insomnia
NCT ID NCT04007796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a behavioral sleep treatment in 36 veterans who have PTSD, insomnia, and sleep apnea. The goal was to see if improving sleep also improves quality of life and daily functioning. Participants attended therapy sessions and reported their sleep and well-being through questionnaires.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
36 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Feb 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Veterans diagnosed with sleep apnea with Apnea Hypopnea Index of at least 5 via sleep study and recommended for PAP therapy * Meet DSM-5 Criteria for Posttraumatic Stress Disorder or subthreshold Posttraumatic Stress Disorder * Meet DSM-5 Criteria for Insomnia Disorder * Willing to attend all treatment and assessment appointments * English literacy and cognition sufficient to participate in treatment and assessment Exclusion Criteria: * Psychosis or manic episode in last 5 years * Moderate or severe substance use disorder in past 6 months * Started or ended psychotherapy for a sleep disorder or mental health diagnosis within the last 1 month or plans to discontinue this treatment during the trial * Started or ended an antidepressant, anxiolytic, or sleep medication with the last 1 month or plans to discontinue this treatment during the trial * Prominent suicidal or homicidal ideation requiring alternative treatment for patient safety * Untreated sleep disorders that may interfere with successful treatment (up to discretion of Principal Investigator) * Having travel of personal plans that would disrupt regular treatment engagement (up to discretion of Principal Investigator) * Working night shifts or rotating shifts that include night shifts * Lack of stable housing * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Insomnia disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, 94121-1563, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can adding ketamine to propofol improve sleep apnea scans?
- Your phone could flag sleep apnea while you sleep
- Can cramming PTSD therapy into a few weeks help veterans cut substance use?
- Can targeting guilt ease PTSD in veterans?
- Can a sleep apnea machine match the gold standard in detecting breathing pauses?
- Can airway shape predict sleep apnea severity?